All In Biotech

Drug Trial Radar · NCT01984008

A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

A Prospective, Randomized Controlled Clinical Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

Last checked: Nov 20, 2026Latest source record: Mar 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 631 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

631

Actual

Start

Oct 23, 2013

Primary completion

Mar 24, 2014

Study completion Jun 17, 2014

Sponsor

Lead sponsor
Universal Integrated Corp.Industry
Sponsor type
Industry
First posted
Nov 14, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to demonstrate that investigation medication (Bowklean) is not less effective than the active comparator (Klean-Prep with Dulcolax), with regards to the overall quality of bowel preparation in subjects undergoing colonoscopy. An additional objective of this study is to collect subject's response to the acceptability and tolerability about bowel preparation and safety information. After bowel preparation, independent evaluator who is blinded to subject's treatment will evaluate the overall colon cleansing based on Aronchick and Ottawa scale. A total of 600 eligible subjects scheduled to a colonoscopy will be randomly assigned with equal allocation to 1 of 2 treatment groups: "Bowklean" or "Klean-Prep" with Dulcolax. Each subject's participation is expected to be maximally 4 weeks in study duration (up to 3-week screening period followed by one week post colonoscopy).

Conditions

  • Bowel Preparation Before Colonoscopy

Interventions

  • Picosulfate sodium, magnesium oxide, citric acidDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage of subjects that achieve excellent or good cleansing (success rate) in the Aronchick Scale.Time frame: six months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • China Medical University Hospital

    Taichung, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.